Back to Search Start Over

Chronic urticaria patients are interested in apps to monitor their disease activity and control: A UCARE CURICT analysis

Authors :
Ivan Cherrez‐Ojeda
Emanuel Vanegas
Annia Cherrez
Miguel Felix
Karsten Weller
Markus Magerl
Rasmus Robin Maurer
Valeria L. Mata
Alicja Kasperska‐Zajac
Agnieszka Sikora
Daria Fomina
Elena Kovalkova
Kiran Godse
Nimmagadda Dheeraj Rao
Maryam Khoshkhui
Sahar Rastgoo
Roberta F. J. Criado
Mohamed Abuzakouk
Deepa Grandon
Martijn B. A. Van Doorn
Solange Oliveira Rodrigues Valle
Eduardo Magalhães De Souza Lima
Simon Francis Thomsen
German D. Ramón
Edgar E. Matos Benavides
Andrea Bauer
Ana M. Giménez‐Arnau
Emek Kocatürk
Carole Guillet
Jose Ignacio Larco
Zuo‐Tao Zhao
Michael Makris
Carla Ritchie
Paraskevi Xepapadaki
Luis Felipe Ensina
Sofia Cherrez
Marcus Maurer
Dermatology
Göncü, Özgür Emek Kocatürk (ORCID 0000-0003-2801-0959 & YÖK ID 217219)
Cherrez-Ojeda, Ivan
Vanegas, Emanuel
Cherrez, Annia
Felix, Miguel
Weller, Karsten
Magerl, Markus
Maurer, Rasmus Robin
Mata, Valeria L.
Kasperska-Zajac, Alicja
Sikora, Agnieszka
Fomina, Daria
Kovalkova, Elena
Godse, Kiran
Rao, Nimmagadda Dheeraj
Khoshkhui, Maryam
Rastgoo, Sahar
Criado, Roberta F. J.
Abuzakouk, Mohamed
Grandon, Deepa
Van Doorn, Martijn B. A.
Rodrigues Valle, Solange Oliveira
De Souza Lima, Eduardo Magalhaes
Thomsen, Simon Francis
Ramón, German D.
Matos Benavides, Edgar E.
Bauer, Andrea
Giménez-Arnau, Ana M.
Guillet, Carole
Larco, Jose Ignacio
Zhao, Zuo-Tao
Makris, Michael
Ritchie, Carla
Xepapadaki, Paraskevi
Ensina, Luis Felipe
Cherrez, Sofia
Maurer, Marcus
School of Medicine
Publica
Source :
Clinical and Translational Allergy, Vol 11, Iss 10, Pp n/a-n/a (2021), Clinical and Translational Allergy, 11(10):e12089. BioMed Central Ltd., Clinical and Translational Allergy, Cherrez-Ojeda, I, Vanegas, E, Cherrez, A, Felix, M, Weller, K, Magerl, M, Maurer, R R, Mata, V L, Kasperska-Zajac, A, Sikora, A, Fomina, D, Kovalkova, E, Godse, K, Rao, N D, Khoshkhui, M, Rastgoo, S, Criado, R F J, Abuzakouk, M, Grandon, D, Van Doorn, M B A, Rodrigues Valle, S O, De Souza Lima, E M, Thomsen, S F, Ramón, G D, Matos Benavides, E E, Bauer, A, Giménez-Arnau, A M, Kocatürk, E, Guillet, C, Larco, J I, Zhao, Z T, Makris, M, Ritchie, C, Xepapadaki, P, Ensina, L F, Cherrez, S & Maurer, M 2021, ' Chronic urticaria patients are interested in apps to monitor their disease activity and control : A UCARE CURICT analysis ', Clinical and Translational Allergy, vol. 11, no. 10, e12089 . https://doi.org/10.1002/clt2.12089
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

Background: information/communication technologies such as mobile phone applications (apps) would enable chronic urticaria (CU) patients to self-evaluate their disease activity and control. Yet, recently Antó et al (2021) reported a global paucity of such apps for patients with CU. In this analysis, we assessed patient interest in using apps to monitor CU disease activity and control using questions from the chronic urticaria information and communication technologies (CURICT) study. Methods: the methodology for CURICT has been reported. Briefly, a 23-item questionnaire was completed by 1841 CU patients from 17 UCAREs across 17 countries. Here, we analyzed patient responses to the CURICT questions on the use of apps for urticaria-related purposes. Results: as previously published, the majority of respondents had chronic spontaneous urticaria (CSU; 63%; 18% chronic inducible urticaria (CIndU) [CIndu]; 19% with both), were female (70%) and in urban areas (75%). Over half of patients were very/extremely interested in an app to monitor disease activity (51%) and control (53%), while only ?1/10 were not. Patients with both urticaria types versus those with CSU only (odds ratio [OR], 1.36 [1.03-1.79]) and females versus males (OR [95% CI], 1.47 [1.17-1.85]) were more likely to be very to extremely interested in an app to assess disease control. Conclusions: overall, half of the patients with CU were very to extremely interested in using an app to assess their disease activity and control. Development of well-designed apps, specific to disease types (CSU, CIndU, CSU + CIndU, etc), validated by experts across platforms would help improve the management and possibly outcomes of CU treatment while providing important patient information to be used in future research. Keywords: UCARE; apps; chronic inducible urticaria; chronic spontaneous urticaria; chronic urticaria; chronische induzierbare urtikaria; chronische spontane urtikaria; chronische urtikaria.<br />UCARE

Details

Language :
English
ISSN :
20457022
Volume :
11
Issue :
10
Database :
OpenAIRE
Journal :
Clinical and Translational Allergy
Accession number :
edsair.doi.dedup.....9261e2f85279aa762e4af7f4a0db8a01
Full Text :
https://doi.org/10.1002/clt2.12089